Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma × vinflunine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 12 Carcinoma, Transitional Cell 7 Neoplasm Metastasis 5 Breast Neoplasms 5 Ureteral Neoplasms 4 Neoplasms 4 Urethral Neoplasms 2 Recurrence 2 Lung Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Urothelial Cancer 1 Urologic Neoplasms 1 Urogenital Neoplasms 1 Unspecified Adult Solid Tumor, Protocol Specific 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Renal Insufficiency 1 Prostatic Neoplasms 1 Penile Neoplasms 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Locally Advanced or Metastatic Unresectable Urothelial Cancer 1 Kidney Neoplasms 1 Carcinoma, Small Cell 1 Carcinoma 1 Breast Neoplasms, Male 1

Interventions

Cisplatin 46 Carboplatin 43 pembrolizumab 39 Paclitaxel 38 Gemcitabine 27 Radiotherapy 19 Pemetrexed 19 Magnetic Resonance Spectroscopy 18 Radiotherapy, Intensity-Modulated 17 Docetaxel 17 Cetuximab 16 Specimen Handling 15 Nivolumab 15 Cyclophosphamide 14 durvalumab 13 Fluorouracil 13 Sorafenib 10 Bevacizumab 10 130-nm albumin-bound paclitaxel 10 Sunitinib 9 Platinum 9 osimertinib 8 Radiation 8 Oxaliplatin 8 Irinotecan 8 Everolimus 8 Capecitabine 8 1,2-diaminocyclohexaneplatinum II citrate 8 Ipilimumab 7 Drug Therapy 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01529411 2019-04-04

MAJA

Spanish Oncology Genito-Urinary Group

Phase 2 Completed

Carcinoma, Carcinoma, Transitional Cell, Neoplasm Metastasis, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡